Bai Ye
Geen lopende functies
Profiel
Bai Ye, who goes by the name Ms. Ye, has worked as a Chief Risk Officer at Huarong International Financial Holdings Ltd., a Department General Manager at Huarong International Trust Co., Ltd., Head-Finance Department at Hebei Huari Pharmaceutical Co. Ltd., and Deputy Senior Manager-Marketing Department at China Huarong Asset Management Co., Ltd.
Eerdere bekende functies van Bai Ye
Bedrijven | Functie | Einde |
---|---|---|
Huarong International Trust Co., Ltd.
Huarong International Trust Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Part of China Trust Protection Fund Co. Ltd., Huarong International Trust Co., Ltd. is a Chinese company that provides trust services. The company is based in Beijing, China. The company was founded in 2008. The CEO is Yi Ming Shen. Huarong International Trust Co. was acquired by China Trust Protection Fund Co. Ltd. from China Huarong Asset Management Co., Ltd. on December 29, 2022 for $909.69 million. | Corporate Officer/Principal | - |
Hebei Huari Pharmaceutical Co. Ltd. | Corporate Officer/Principal | - |
CHINA CITIC FINANCIAL ASSET MANAGEMENT CO., LTD. | Corporate Officer/Principal | - |
HUARONG INTERNATIONAL FINANCIAL HOLDINGS LIMITED | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
HUARONG INTERNATIONAL FINANCIAL HOLDINGS LIMITED | Finance |
CHINA CITIC FINANCIAL ASSET MANAGEMENT CO., LTD. | Finance |
Bedrijven in privébezit | 2 |
---|---|
Huarong International Trust Co., Ltd.
Huarong International Trust Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Part of China Trust Protection Fund Co. Ltd., Huarong International Trust Co., Ltd. is a Chinese company that provides trust services. The company is based in Beijing, China. The company was founded in 2008. The CEO is Yi Ming Shen. Huarong International Trust Co. was acquired by China Trust Protection Fund Co. Ltd. from China Huarong Asset Management Co., Ltd. on December 29, 2022 for $909.69 million. | Miscellaneous |
Hebei Huari Pharmaceutical Co. Ltd. |